Turtle Cameron - Insider Non-Derivative Transactions at Spyre Therapeutics, Inc. (SYRE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, Turtle Cameron's relationship to Spyre Therapeutics, Inc. (SYRE) is Director,Officer (Chief Executive Officer), and currently has 690,912 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SYRE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Turtle Cameron - Insider Non-Derivative Transactions of SYRE Common Stock

Turtle Cameron - Insider Non-Derivative Transactions at SYRE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	Sell -- (Common Stock)	4005	29.83	686907
Dec 2, 2025	Sell -- (Common Stock)	10995	28.73	690912
Nov 4, 2025	Sell -- (Common Stock)	16845	23.66	701907
Nov 4, 2025	Sell -- (Common Stock)	28155	23.13	718752
Feb 16, 2024	Acquisition -- (Common Stock)	400	9.82	746907